Recently, Sinoparmaceutical Engineering successfully won the bid for the natural anti-tumor drug research and development production base project of Yibin Bohui Biotechnology Co., Ltd.

The project plans to invest20100 million yuan, planned construction land area120 mu, the construction of paclitaxel natural anti-tumor drug research and development, production and sales base, will produce high-purity paclitaxel (≥99.5 percent), human albumin paclitaxel injection finished preparations and other products, the project is expected to achieve annual output value after full production.

The successful bid of the project will further expand the brand influence of Sinopharm Engineering in the field of biomedical design, and provide strong momentum for the development of biomedical industry in Yibin.

(Contributed by Wuhan Company)